Development of Piperine-Loaded Solid Self-Nanoemulsifying Drug Delivery System: Optimization, In-Vitro, Ex-Vivo, and In-Vivo Evaluation.

antihypertensive activity antimicrobial activity oral delivery piperine solid self nanoemusifying

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
31 Oct 2021
Historique:
received: 11 09 2021
revised: 28 10 2021
accepted: 29 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Hypertension is a cardiovascular disease that needs long-term medication. Oral delivery is the most common route for the administration of drugs. The present research is to develop piperine self-nanoemulsifying drug delivery system (PE-SNEDDS) using glyceryl monolinoleate (GML), poloxamer 188, and transcutol HP as oil, surfactant, and co-surfactant, respectively. The formulation was optimized by three-factor, three-level Box-Behnken design. PE-SNEDDs were characterized for globule size, emulsification time, stability, in-vitro release, and ex-vivo intestinal permeation study. The optimized PE-SNEDDS (OF3) showed the globule size of 70.34 ± 3.27 nm, percentage transmittance of 99.02 ± 2.02%, and emulsification time of 53 ± 2 s Finally, the formulation OF3 was transformed into solid PE-SNEDDS (S-PE-SNEDDS) using avicel PH-101 as adsorbent. The reconstituted SOF3 showed a globule size of 73.56 ± 3.54 nm, PDI of 0.35 ± 0.03, and zeta potential of -28.12 ± 2.54 mV. SEM image exhibited the PE-SNEDDS completely adsorbed on avicel. Thermal analysis showed the drug was solubilized in oil, surfactant, and co-surfactant. S-PE-SNEDDS formulation showed a more significant (

Identifiants

pubmed: 34835684
pii: nano11112920
doi: 10.3390/nano11112920
pmc: PMC8624913
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Taif University Researchers Supporting Project number Taif University, Taif, Saud Arabia.
ID : (TURSP-2020/50),

Références

Pharmaceuticals (Basel). 2020 Jul 24;13(8):
pubmed: 32722238
Antibiotics (Basel). 2019 May 04;8(2):
pubmed: 31060239
Biomed Res Int. 2018 Sep 27;2018:6763057
pubmed: 30363745
J Pharm Biomed Anal. 2015 Nov 10;115:144-9
pubmed: 26201645
Molecules. 2020 Oct 14;25(20):
pubmed: 33066657
Drug Deliv. 2015;22(6):740-7
pubmed: 24670090
Colloids Surf B Biointerfaces. 2013 Dec 1;112:337-43
pubmed: 24012665
Int J Biol Macromol. 2018 Jan;106:425-432
pubmed: 28802847
AAPS PharmSciTech. 2012 Dec;13(4):1416-27
pubmed: 23070560
Int J Nanomedicine. 2019 Jul 05;14:4949-4960
pubmed: 31308665
AAPS PharmSciTech. 2016 Oct;17(5):1240-7
pubmed: 26573159
Pharmaceutics. 2020 Jul 25;12(8):
pubmed: 32722400
Eur J Pharm Biopharm. 2011 Oct;79(2):250-7
pubmed: 21550401
Drug Dev Ind Pharm. 2016;42(2):288-306
pubmed: 26087658
Int J Immunopharmacol. 2000 Sep;22(9):729-40
pubmed: 10884593
Int J Pharm. 2018 Mar 1;538(1-2):40-47
pubmed: 29294324
Int J Nanomedicine. 2019 Jul 18;14:5435-5448
pubmed: 31409997
Oxid Med Cell Longev. 2019 Apr 16;2019:1309175
pubmed: 31178949
Drug Deliv Transl Res. 2021 Feb;11(1):118-130
pubmed: 32016707
ISRN Pharm. 2012;2012:195727
pubmed: 22830056
Pharmaceutics. 2020 May 06;12(5):
pubmed: 32384817
J Adv Res. 2016 May;7(3):423-34
pubmed: 27222747
Biomed Res Int. 2017;2017:6761452
pubmed: 28884127
J Microencapsul. 2017 May;34(3):319-333
pubmed: 28481663
Int J Nanomedicine. 2015 Jul 29;10:4797-813
pubmed: 26251598
J Cardiovasc Pharmacol. 2008 Nov;52(5):452-8
pubmed: 19033825
Front Bioeng Biotechnol. 2020 May 14;8:425
pubmed: 32478050
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
Pharmaceutics. 2020 Aug 04;12(8):
pubmed: 32759764
Eur J Pharm Sci. 2019 Sep 1;137:104988
pubmed: 31291598
Planta Med. 2019 Feb;85(3):249-257
pubmed: 30357764
Biomaterials. 2012 Oct;33(28):6758-68
pubmed: 22748771
Int J Nanomedicine. 2021 Feb 09;16:905-924
pubmed: 33603359

Auteurs

Ameeduzzafar Zafar (A)

Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi Arabia.

Syed Sarim Imam (SS)

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Nabil K Alruwaili (NK)

Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi Arabia.

Omar Awad Alsaidan (OA)

Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi Arabia.

Mohammed H Elkomy (MH)

Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi Arabia.

Mohammed M Ghoneim (MM)

Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia.

Sultan Alshehri (S)

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Ahmed Mahmoud Abdelhaleem Ali (AMA)

Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.

Khalid Saad Alharbi (KS)

Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi Arabia.

Mohd Yasir (M)

Department of Pharmacy, College of Health Sciences, Arsi University, Asella P.O. Box 396, Ethiopia.

Kaveripakkam M Noorulla (KM)

Department of Pharmacy, College of Health Sciences, Arsi University, Asella P.O. Box 396, Ethiopia.

Sami I Alzarea (SI)

Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi Arabia.

Abdullah S Alanazi (AS)

Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi Arabia.
Health Sciences Research Unit, Jouf University, Sakaka 72341, Al-Jouf, Saudi Arabia.

Classifications MeSH